ZA847890B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: ZA847890B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1983-10-10

Application number

ZA847890A

Other languages

English (en)

Inventor

Eberhard Fritz Gottwald

Horst Manfred Machoczek

Original Assignee

Smithkline Dauelsberg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-10-10

Filing date

1984-10-09

Publication date

1985-05-29

1984-10-09 Application filed by Smithkline Dauelsberg filed Critical Smithkline Dauelsberg

1985-05-29 Publication of ZA847890B publication Critical patent/ZA847890B/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Jellies, Jams, And Syrups (AREA)

ZA847890A 1983-10-10 1984-10-09 Pharmaceutical compositions ZA847890B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP83306112		1983-10-10

Publications (1)

Publication Number	Publication Date
ZA847890B true ZA847890B (en)	1985-05-29

Family

ID=8191309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA847890A ZA847890B (en)	1983-10-10	1984-10-09	Pharmaceutical compositions

Country Status (10)

Country	Link
US (1)	US4861592A (fr)
EP (1)	EP0138540B1 (fr)
JP (1)	JPS61500223A (fr)
AU (1)	AU560608B2 (fr)
CA (1)	CA1239349A (fr)
DE (1)	DE3467703D1 (fr)
DK (1)	DK163959C (fr)
IE (1)	IE57706B1 (fr)
WO (1)	WO1985001656A1 (fr)
ZA (1)	ZA847890B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6036479A (ja) *	1983-08-08	1985-02-25	Kotobuki Seiyaku Kk	１，３−ジオキサン誘導体、本化合物を有効成分とする抗潰瘍剤及びその製造方法
US5994041A (en) *	1985-04-06	1999-11-30	Eastman Kodak Company	Process for buffering concentrated aqueous slurries
GB8618847D0 (en) *	1986-08-01	1986-09-10	Smith Kline French Lab	Pharmaceutical formulations
NL194638C (nl) *	1986-12-19	2002-10-04	Novartis Ag	Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
US5288500A (en) *	1987-03-13	1994-02-22	Benzon Pharma A/S	Oral composition containing particles comprising an active substance
DK130287D0 (da) *	1987-03-13	1987-03-13	Benzon As Alfred	Oralt praeparat
ATE73328T1 (de) *	1987-05-08	1992-03-15	Smith Kline French Lab	Pharmazeutische zusammensetzungen.
GB8710965D0 (en) *	1987-05-08	1987-06-10	Smith Kline French Lab	Pharmaceutical compositions
SE8704436D0 (sv) *	1987-11-13	1987-11-13	Pm Konsult Handelsbolag	Anvendning av antisekretoriska substanser for nya indikationer
JP2643260B2 (ja) *	1988-03-22	1997-08-20	藤沢薬品工業株式会社	シロップ剤
US5209724A (en) *	1988-04-11	1993-05-11	Dhaliwal Avtar S	Composite anesthetic article and method of use
US5226901A (en) *	1988-04-11	1993-07-13	Dhaliwal Avtar S	Composite anesthetic article and method of use
YU120988A (en) *	1988-06-23	1990-06-30	Lek Tovarna Farmacevtskih	Process for preparing new dispersion pills of cimetidine
CA2061520C (fr) *	1991-03-27	2003-04-22	Lawrence J. Daher	Systeme de delivrance accelerant l'effet et accroissant la puissance
NZ243567A (en) *	1991-07-22	1995-04-27	Bristol Myers Squibb Co	Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US5229137A (en) *	1992-05-06	1993-07-20	Brigham And Women's Hospital, Inc.	Methods and pharmaceutical compositions for treating episodic heartburn
AU2584092A (en) *	1992-09-03	1994-03-29	Affinity Biotech, Inc.	Taste-masking pharmaceutical compositions and methods for making the same
IT1256616B (it) *	1992-12-02	1995-12-12	Zambon Spa	Sciroppo contenente n-acetil-cisteina
WO1994025006A1 (fr) *	1993-04-26	1994-11-10	Affinity Biotech, Inc.	Compositions pharmaceutiques masquant le gout et leurs procedes de production
US5609998A (en) *	1994-12-29	1997-03-11	Eastman Kodak Company	Process for dispersing concentrated aqueous slurries
DE19529862A1 (de) *	1995-08-14	1997-02-20	Rhone Poulenc Rorer Gmbh	Pharmazeutische, oral anwendbare Zubereitung
US5989588A (en) *	1996-10-04	1999-11-23	Merck & Co., Inc.	Methods and compositions for preventing and treating heartburn
AU728423B2 (en) *	1996-10-04	2001-01-11	Mcneil-Ppc, Inc.	Methods and compositions for preventing and treating heartburn
AU730391B2 (en) *	1996-10-10	2001-03-08	Mcneil-Ppc, Inc.	Liquid antacid compositions
US5976578A (en) *	1996-10-10	1999-11-02	Mcneil-Ppc, Inc.	Liquid antacid compositions
CA2305179A1 (fr) *	1997-09-30	1999-04-08	Daiichi Pharmaceutical Co., Ltd.	Preparation orale
GB0001315D0 (en) *	2000-01-20	2000-03-08	Novartis Ag	Organic compounds
US6515008B1 (en) *	2000-05-04	2003-02-04	Smithkline Beecham Corporation	Formulation
WO2003077842A2 (fr) *	2002-03-12	2003-09-25	Bristol-Myers Squibb Company	Suspension orale de gout agreable et procede associe
PE20060935A1 (es) *	2004-10-21	2006-10-26	Novartis Ag	Composicion farmaceutica que comprende diclofenaco
US7776831B2 (en)	2006-02-01	2010-08-17	Weg Stuart L	Use of antifungal compositions to treat upper gastrointestinal conditions
DE102010049708A1 (de) *	2010-10-28	2012-05-03	Hexal Ag	Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
MX349803B (es) *	2011-02-11	2017-08-14	Ctc Bio Inc	Preparación farmacéutica de película que contiene sildenafil en su forma de base libre y método para producir dicha preparación.
EP2952103B1 (fr) *	2014-06-05	2019-05-08	Symrise AG	Mixtures de matières

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1550359A (en) *	1975-08-07	1979-08-15	Beecham Group Ltd	Antibiotic compositions for oral administration
EP0040489A1 (fr) *	1980-05-17	1981-11-25	FISONS plc	Mélanges, sels, emballages et compositions pharmaceutiques contenant l'acide 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyrane-2-carboxylique ou un de ses dérivés et une antihistamine antagoniste des récepteurs H2
US4427681A (en) *	1982-09-16	1984-01-24	Richardson-Vicks, Inc.	Thixotropic compositions easily convertible to pourable liquids

1984
- 1984-10-04 CA CA000464707A patent/CA1239349A/fr not_active Expired
- 1984-10-08 DE DE8484306833T patent/DE3467703D1/de not_active Expired
- 1984-10-08 EP EP84306833A patent/EP0138540B1/fr not_active Expired
- 1984-10-08 AU AU35039/84A patent/AU560608B2/en not_active Expired
- 1984-10-08 WO PCT/GB1984/000347 patent/WO1985001656A1/fr not_active Ceased
- 1984-10-08 JP JP59503756A patent/JPS61500223A/ja active Pending
- 1984-10-09 ZA ZA847890A patent/ZA847890B/xx unknown
- 1984-10-09 IE IE2579/84A patent/IE57706B1/en not_active IP Right Cessation
1985
- 1985-06-07 DK DK257485A patent/DK163959C/da not_active IP Right Cessation
1987
- 1987-06-02 US US07/057,578 patent/US4861592A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK163959C (da)	1992-09-21
AU560608B2 (en)	1987-04-09
CA1239349A (fr)	1988-07-19
IE57706B1 (en)	1993-03-10
JPS61500223A (ja)	1986-02-06
EP0138540B1 (fr)	1987-11-25
IE842579L (en)	1985-04-10
US4861592A (en)	1989-08-29
EP0138540A3 (en)	1985-05-22
DE3467703D1 (en)	1988-01-07
AU3503984A (en)	1985-05-07
DK257485D0 (da)	1985-06-07
DK163959B (da)	1992-04-27
DK257485A (da)	1985-06-07
EP0138540A2 (fr)	1985-04-24
WO1985001656A1 (fr)	1985-04-25

Publication	Publication Date	Title
GB2136807B (en)	1987-04-23	Pharmaceutical compositions
GB8423339D0 (en)	1984-10-17	Pharmaceutical compositions
GB8403668D0 (en)	1984-03-14	Pharmaceutical compositions
DE3467703D1 (en)	1988-01-07	Pharmaceutical compositions
GB8412108D0 (en)	1984-06-20	Pharmaceutical compositions
GB8423799D0 (en)	1984-10-24	Pharmaceutical compositions
GB8415975D0 (en)	1984-07-25	Pharmaceutical compositions
GB8308126D0 (en)	1983-05-05	Pharmaceutical compositions
GB8423800D0 (en)	1984-10-24	Pharmaceutical compositions
GB8329043D0 (en)	1983-11-30	Pharmaceutical compositions
GB2136806B (en)	1987-04-15	Pharmaceutical compositions
GB8317595D0 (en)	1983-08-03	Pharmaceutical compositions
CY1503A (en)	1990-08-03	Pharmaceutical compositions
GB8412569D0 (en)	1984-06-20	Pharmaceutical compositions
GR80223B (en)	1985-01-02	Pharmaceutical compositions
GB8406132D0 (en)	1984-04-11	Pharmaceutical compositions
GR80238B (en)	1985-01-02	Pharmaceutical compositions
GB8300767D0 (en)	1983-02-16	Pharmaceutical compositions
GB8416358D0 (en)	1984-08-01	Pharmaceutical compositions
GB8305697D0 (en)	1983-04-07	Pharmaceutical compositions
GB8425250D0 (en)	1984-11-14	Pharmaceutical compositions
GB2150435B (en)	1986-10-15	Pharmaceutical compositions
GB8323623D0 (en)	1983-10-05	Pharmaceutical compositions
GB8325628D0 (en)	1983-10-26	Pharmaceutical compositions
GB8331776D0 (en)	1984-01-04	Pharmaceutical compositions